The estimates which had been reported by the Working Group on Trends in the Demand for Blood Products in late 1977 were largely thought to be reliable estimates for future need by the Standing Medical Advisory Committee in 1978. Read more about The estimates which had been reported by the Working Group on Trends in the Demand for Blood Products in late 1977 were largely thought to be reliable estimates for future need by the Standing Medical Advisory Committee in 1978.
The Working Group on Trends in the Demand for Blood Products noted in its July meeting that the size of the population with haemophilia could rise significantly. They also said: "It was apparent that clinicians were coming to recognise the supply problems; eg, they were moderating their demands for Factor VIII for prophylactic treatment." Read more about The Working Group on Trends in the Demand for Blood Products noted in its July meeting that the size of the population with haemophilia could rise significantly. They also said: "It was apparent that clinicians were coming to recognise the supply problems; eg, they were moderating their demands for Factor VIII for prophylactic treatment."
The Working Group on Trends in the Demand for Blood Products held its first meeting. Read more about The Working Group on Trends in the Demand for Blood Products held its first meeting.
The minutes of a haemophilia centre directors' meeting noted that there was a hold up in the expansion of fractionation in the UK. Read more about The minutes of a haemophilia centre directors' meeting noted that there was a hold up in the expansion of fractionation in the UK.
The draft proof of "Evidence of Dr Lane for HIV Litigation" noted that Dr Ethel Bidwell's note on the production of Factor 8 concentrate (including arithmetic on the basis of yields) in January 1976 was far closer to what Dr Lane would consider realistic. Read more about The draft proof of "Evidence of Dr Lane for HIV Litigation" noted that Dr Ethel Bidwell's note on the production of Factor 8 concentrate (including arithmetic on the basis of yields) in January 1976 was far closer to what Dr Lane would consider realistic.
A document by T Dutton outlined problems facing the National Blood Transfusion Service, particularly with regard to the provision of blood components. Read more about A document by T Dutton outlined problems facing the National Blood Transfusion Service, particularly with regard to the provision of blood components.
In a National Blood Transfusion Service Central Committee meeting, the chairman proposed a review of the clinical use of blood and blood products, including an examination of the overall use of the blood and blood fractions. Read more about In a National Blood Transfusion Service Central Committee meeting, the chairman proposed a review of the clinical use of blood and blood products, including an examination of the overall use of the blood and blood fractions.
A letter from Gerry Grimstone to Thomas Dutton outlined Dr Owen's stance that the National Blood Transfusion Service needed to be reformed. Read more about A letter from Gerry Grimstone to Thomas Dutton outlined Dr Owen's stance that the National Blood Transfusion Service needed to be reformed.
A note on anti-haemophilic globulin concentrate outlined that the target figure to which they were currently working was no longer sufficient to meet the probable treatment needs of people with haemophilia in a few years time, having been overtaken by the unexpected rapid introduction of home therapy. Read more about A note on anti-haemophilic globulin concentrate outlined that the target figure to which they were currently working was no longer sufficient to meet the probable treatment needs of people with haemophilia in a few years time, having been overtaken by the unexpected rapid introduction of home therapy.
A memo from Thomas Dutton noted that a recent meeting of the Expert Group on the Treatment of Haemophilia advised that NHS Factor 8 production may have provided no more than about one third of the likely requirement for Factor 8 in a few years time. Read more about A memo from Thomas Dutton noted that a recent meeting of the Expert Group on the Treatment of Haemophilia advised that NHS Factor 8 production may have provided no more than about one third of the likely requirement for Factor 8 in a few years time.